ANIX
Price
$2.97
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
95.67M
6 days until earnings call
GLUE
Price
$4.94
Change
+$0.03 (+0.61%)
Updated
Sep 5 closing price
Capitalization
305.09M
61 days until earnings call
Interact to see
Advertisement

ANIX vs GLUE

Header iconANIX vs GLUE Comparison
Open Charts ANIX vs GLUEBanner chart's image
Anixa Biosciences
Price$2.97
Change-$0.00 (-0.00%)
Volume$36.4K
Capitalization95.67M
Monte Rosa Therapeutics
Price$4.94
Change+$0.03 (+0.61%)
Volume$330.61K
Capitalization305.09M
ANIX vs GLUE Comparison Chart in %
Loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIX vs. GLUE commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Hold and GLUE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ANIX: $2.97 vs. GLUE: $4.94)
Brand notoriety: ANIX and GLUE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 42% vs. GLUE: 82%
Market capitalization -- ANIX: $95.67M vs. GLUE: $305.09M
ANIX [@Biotechnology] is valued at $95.67M. GLUE’s [@Biotechnology] market capitalization is $305.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whileGLUE’s FA Score has 0 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • GLUE’s FA Score: 0 green, 5 red.
According to our system of comparison, GLUE is a better buy in the long-term than ANIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 4 TA indicator(s) are bullish while GLUE’s TA Score has 5 bullish TA indicator(s).

  • ANIX’s TA Score: 4 bullish, 5 bearish.
  • GLUE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, GLUE is a better buy in the short-term than ANIX.

Price Growth

ANIX (@Biotechnology) experienced а -0.67% price change this week, while GLUE (@Biotechnology) price change was +2.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ANIX is expected to report earnings on Sep 12, 2025.

GLUE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($305M) has a higher market cap than ANIX($95.7M). ANIX YTD gains are higher at: 28.017 vs. GLUE (-28.818). GLUE has higher annual earnings (EBITDA): 23.3M vs. ANIX (-13.11M). GLUE has more cash in the bank: 291M vs. ANIX (15.6M). ANIX has less debt than GLUE: ANIX (221K) vs GLUE (41.1M). GLUE has higher revenues than ANIX: GLUE (178M) vs ANIX (0).
ANIXGLUEANIX / GLUE
Capitalization95.7M305M31%
EBITDA-13.11M23.3M-56%
Gain YTD28.017-28.818-97%
P/E RatioN/A12.67-
Revenue0178M-
Total Cash15.6M291M5%
Total Debt221K41.1M1%
FUNDAMENTALS RATINGS
ANIX: Fundamental Ratings
ANIX
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANIXGLUE
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 16 days ago
84%
Bullish Trend 4 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ECLMF0.15N/A
N/A
Ecolomondo Corp.
HLNFF11.48N/A
N/A
High Liner Foods Inc.
DTWOF0.03N/A
N/A
D2 LITHIUM CORP.
KAJMY27.31N/A
N/A
Kajima Corp.
TDBOY28.11N/A
N/A
Toyota Boshoku Corp.

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with LGND. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then LGND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
N/A
LGND - ANIX
36%
Loosely correlated
-0.59%
GLUE - ANIX
35%
Loosely correlated
+0.61%
KLTO - ANIX
33%
Loosely correlated
-2.00%
VERA - ANIX
32%
Poorly correlated
+10.46%
IBRX - ANIX
31%
Poorly correlated
+0.42%
More

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with EYPT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
+0.61%
EYPT - GLUE
48%
Loosely correlated
+17.93%
NRIX - GLUE
40%
Loosely correlated
+8.66%
ITRM - GLUE
40%
Loosely correlated
+7.31%
FATE - GLUE
39%
Loosely correlated
+3.81%
IMNM - GLUE
39%
Loosely correlated
+7.35%
More